ADA 2025 & AACE 2023 Guidelines: Pharmacologic Management of Type 2 Diabetes

Access the most up-to-date American Diabetes Association (ADA) 2025 Standards of Care alongside the American Association of Clinical Endocrinology (AACE) 2023 Clinical Practice Guideline for a synchronized view of glucose-lowering therapy in adults with Type 2 diabetes.

For In-Depth Reference

  • Use the sidebar button(s) to download each complete guideline PDF.
  • Both documents include fully graded recommendations, evidence tables, and clinical insights—ideal for comprehensive professional review.

For a Quick Overview

  • Consult the comparative algorithm chart below.
  • The visual highlights areas of overlap and divergence in first-line, add-on, and comorbidity-focused therapy, streamlining navigation of core ADA and AACE pharmacotherapy recommendations.

Healthcare Professionals Only

This website contains scientific and medical information intended exclusively for healthcare professionals (HCPs). If you are not a healthcare professional, please exit this site and visit www.spartina.ir

محتوای ویژه پزشکان

این وب‌سایت حاوی اطلاعات علمی و پزشکی است که صرفاً برای استفاده پزشکان طراحی شده است. اگر شما از کادر درمان نیستید، لطفاً این وب‌سایت را ترک کرده و به www.spartina.ir مراجعه کنید